
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy Inc. demonstrated robust financial performance with a sequential 2.2% increase in commercial pricing, indicating strong pricing power in its outpatient physical therapy clinics. Additionally, revenue from its Industrial Injury Prevention (IIP) segment grew an impressive 22.2% overall, and 18.4% when excluding acquisitions, reflecting the company's successful expansion and operational efficiency. Furthermore, the recent acquisition of the Metro business has proven beneficial, as evidenced by the increase in its net rate from approximately $101 to $107.50, underscoring the company's ability to enhance revenue through strategic growth initiatives.
Bears say
US Physical Therapy Inc. has experienced a decline in a key financial metric, with a reduction of 0.6% in value over the year, indicating ongoing pressure on its operations. The company faces significant challenges from five consecutive years of reimbursement cuts, totaling a detrimental $20 million impact on profitability. Additionally, the ratio of rent, clinic, and other expenses, including contract labor, represented 20.2% of revenue, slightly exceeding expectations, further highlighting operational cost pressures.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares